Literature DB >> 21228171

Long-term in vivo imaging of β-amyloid plaque appearance and growth in a mouse model of cerebral β-amyloidosis.

Jasmin K Hefendehl1, Bettina M Wegenast-Braun, Christian Liebig, Daniel Eicke, David Milford, Michael E Calhoun, Shinichi Kohsaka, Martin Eichner, Mathias Jucker.   

Abstract

Extracellular deposition of the amyloid-β peptide (Aβ) in the brain parenchyma is a hallmark lesion of Alzheimer's disease (AD) and a predictive marker for the progression of preclinical to symptomatic AD. Here, we used multiphoton in vivo imaging to study Aβ plaque formation in the brains of 3- to 4-month-old APPPS1 transgenic mice over a period of 6 months. A novel head fixation system provided robust and efficient long-term tracking of single plaques over time. Results revealed an estimated rate of 35 newly formed plaques per cubic millimeter of neocortical volume per week at 4-5 months of age. At later time points (i.e., in the presence of increasing cerebral β-amyloidosis), the number of newly formed plaques decreased. On average, both newly formed and existing plaques grew at a similar growth rate of 0.3 μm (radius) per week. A solid knowledge of the dynamics of cerebral β-amyloidosis in mouse models provides a powerful tool to monitor preclinical Aβ targeting therapeutic strategies and eases the interpretation of diagnostic amyloid imaging in humans.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228171      PMCID: PMC6623424          DOI: 10.1523/JNEUROSCI.5147-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

Review 1.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

2.  Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.

Authors:  Peng Liu; John H Reichl; Eshaan R Rao; Brittany M McNellis; Eric S Huang; Laura S Hemmy; Colleen L Forster; Michael A Kuskowski; David R Borchelt; Robert Vassar; Karen H Ashe; Kathleen R Zahs
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Gestational Stress Augments Postpartum β-Amyloid Pathology and Cognitive Decline in a Mouse Model of Alzheimer's Disease.

Authors:  Zahra Jafari; Jogender Mehla; Bryan E Kolb; Majid H Mohajerani
Journal:  Cereb Cortex       Date:  2019-08-14       Impact factor: 5.357

4.  Two-photon microscopy for chemical neuroscience.

Authors:  Graham C R Ellis-Davies
Journal:  ACS Chem Neurosci       Date:  2011-04-20       Impact factor: 4.418

5.  In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration.

Authors:  Sarah E Crowe; Graham C R Ellis-Davies
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

6.  Stable size distribution of amyloid plaques over the course of Alzheimer disease.

Authors:  Alberto Serrano-Pozo; Matthew L Mielke; Alona Muzitansky; Teresa Gómez-Isla; John H Growdon; Brian J Bacskai; Rebecca A Betensky; Matthew P Frosch; Bradley T Hyman
Journal:  J Neuropathol Exp Neurol       Date:  2012-08       Impact factor: 3.685

Review 7.  Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging.

Authors:  Carlo Condello; Peng Yuan; Jaime Grutzendler
Journal:  Biol Psychiatry       Date:  2017-10-14       Impact factor: 13.382

8.  Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice.

Authors:  Farhan Ali; Stephanie L Baringer; Arianna Neal; Esther Y Choi; Alex C Kwan
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

9.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

10.  Longitudinal in vivo two-photon fluorescence imaging.

Authors:  Sarah E Crowe; Graham C R Ellis-Davies
Journal:  J Comp Neurol       Date:  2014-06-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.